Send Inquiry

Request To Call Back

NOXALK CERITINIB CAPSULES

Get a Price/Quote

MOQ : 1 Bottle

NOXALK CERITINIB CAPSULES Specification

Origin of Medicine
Imported

Salt Composition
Ceritinib

Indication
Treatment of ALK-positive metastatic non-small cell lung cancer

Pacakaging (Quantity Per Box)
30 capsules

Dosage Form
Capsule

Drug Type
Prescription

Ingredients
Ceritinib

Physical Form
Tablets

Function
Anti-cancer / ALK inhibitor

Recommended For
Non-small cell lung cancer (NSCLC) patients

Dosage
As prescribed by the oncologist

Dosage Guidelines
Take at the same time each day, preferably with food

Suitable For
Adults

Quantity
30 Capsules per box

Storage Instructions
Store below 30C, protect from moisture

Marketed By
Natco Pharma Ltd.

Registration Status
Registered

Warning
To be sold by retail on the prescription of a registered medical practitioner only

Strength
150 mg per capsule

Route of Administration
Oral

Drug Class
Tyrosine kinase inhibitor

Color
White to off-white

Shelf Life
24 months from date of manufacture

NOXALK CERITINIB CAPSULES Trade Information

Minimum Order Quantity
1 Bottle

Packaging Details
PACK OF 30 CAPSULES

Main Domestic Market
All India

About NOXALK CERITINIB CAPSULES

PRODUCT DETAILS

BRAND NAME: NOXALK

CONTAINS: CERTINIB

STRENGTH: 150MG

PACKAGING SIZE: PACK OF 30CAPSULES

MANUFACTURED BY: NATCO

Note :-NOXALKIs A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug...............

Precision Treatment for ALK-Positive NSCLC

NOXALK Ceritinib Capsules provide a focused therapy option for adults with ALK-positive metastatic non-small cell lung cancer. By targeting abnormal proteins responsible for cancer cell proliferation, this medication offers a substantial advancement in personalized cancer care.

Simple Oral Administration

Administered orally, NOXALK Ceritinib is easy for patients to integrate into their daily routine. The recommended practice is to take the medication once daily, at the same time, preferably with food, as directed by your oncologist to maximize effectiveness.

Strict Prescription Protocols

Due to its potent anti-cancer effects and potential side effects, NOXALK Ceritinib Capsules require a prescription from a registered medical practitioner. This ensures proper patient selection, dosage adjustment, and monitored therapy throughout the course of treatment.

FAQs of NOXALK CERITINIB CAPSULES:

Q: How should NOXALK Ceritinib Capsules be taken for best results?

A: Take NOXALK Ceritinib Capsules orally, once per day at the same time, preferably with food, exactly as prescribed by your oncologist. Adhering to the dosing schedule helps maintain stable drug levels for optimal effectiveness.

Q: What is NOXALK Ceritinib indicated for in cancer treatment?

A: NOXALK Ceritinib is specifically indicated for the treatment of adult patients with ALK-positive metastatic non-small cell lung cancer (NSCLC). It acts by inhibiting the cancer-driving ALK tyrosine kinase enzyme.

Q: When should I start using NOXALK Ceritinib, and how long does the course last?

A: Treatment start and duration are determined by your oncologist based on your diagnosis and response to therapy. It is vital to attend regular appointments for assessment and dose adjustments as needed.

Q: Where should NOXALK Ceritinib Capsules be stored for safety and potency?

A: Store NOXALK Ceritinib Capsules below 30C, shielded from moisture and direct sunlight. Ensure the medication is kept out of reach of children and only accessible to the prescribed patient.

Q: What benefits does NOXALK Ceritinib offer compared to conventional therapies?

A: NOXALK Ceritinib targets specific molecular mechanisms in ALK-positive cancer cells. This precision approach can provide improved efficacy and sometimes a better side effect profile for eligible NSCLC patients.

Q: Who can use NOXALK Ceritinib Capsules, and are there any restrictions?

A: NOXALK Ceritinib Capsules are suitable for adult patients diagnosed with ALK-positive metastatic NSCLC. They must be prescribed and monitored by a registered oncologist due to safety considerations and individual health factors.

Q: Is NOXALK Ceritinib available for export and supply outside India?

A: Yes, NOXALK Ceritinib is distributed, exported, and supplied by authorized entities including distributors, exporters, suppliers, traders, and wholesalers in India. Export availability depends on local regulations and import requirements.

Tell us about your requirement